Researchers from the University of Cincinnati College of Medicine have developed RNA nanoparticles that show promise in overcoming treatment-resistant breast cancer. The team’s work was published in ACS Nano.
The researchers used a nanocarrier to target HER2-positive breast cancer and stop the production of a specific protein to prevent metastasis and render the cancer cells vulnerable to tamoxifen, a therapy for estrogen-driven cancer.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers use nanoparticles to overcome treatment-resistant breast cancer appeared first on MassDevice.